Skip to main content
Equibles
HCA logo

HCA · HCA Healthcare, Inc. · Analyst Estimates

Track HCA — free

Use HCA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HCA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$449.96 -15.30 (-3.29%) At close · Oct 27 Q3 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$103.21B
Shares
221.84M
Volume · Oct 27 2.91M Avg daily vol (3M) 1.34M

Analyst Estimates

Compare analyst forecasts for HCA Healthcare, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-28 05:06 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
28.62
29.49
30.41
20
29.49
29.49
29.49
29.92
1
1
0
0
Revenue
USD
Publication date not stated
78.31B
78.77B
79.44B
15
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
30.16
31.99
34.04
23
31.99
32.02
32.11
32.18
1
2
0
0
Revenue
USD
Publication date not stated
79.49B
81.57B
82.89B
23
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
7.57
8.06
8.61
20
8.06
8.02
7.97
8.11
1
1
0
2
Revenue
USD
Publication date not stated
19.67B
19.97B
20.23B
14
 — — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
7.18
7.84
8.25
12
7.84
7.82
7.82
7.81
0
1
1
2
Revenue
USD
Publication date not stated
19.65B
19.93B
20.16B
12
 — — — — — — — —
Key facts CIK 860730 CUSIP 40412C101 13F (30d) 410 filings 392 filers Visit website Investor relations